从单胺氧化酶抑制到抗增殖活性:聚胺类型的新生物学前景
Giulia Nordio1,2, Francesco Piazzola1, Giorgio Cozza3
1Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy.
Molecules (Basel, Switzerland)
|September 9, 2023
概括
新的聚胺类同类物被开发为胺氧化酶 (MAO) 的强有力的抑制剂. 这些化合物对质母细胞瘤表现出显著的抗增殖活性,这表明它们可能是针对MAO的新抗癌剂.
科学领域:
- 生物化学 生物化学
- 药用化学 医学化学
- 在瘤学瘤学.
背景情况:
- 单胺氧化酶 (MAO) 是神经系统疾病的确立药物点.
- 最近的研究强调了MAO在质母细胞瘤和前列腺癌等癌症中的过度表达.
- 这表明MAO抑制剂可能是有效的抗增殖剂.
研究的目的:
- 合成和评估新型聚胺类似物作为人类MAO的抑制剂.
- 为了研究受约束链接剂对MAO抑制功能的影响.
- 评估这些类似物对质母细胞瘤细胞的抗增殖活性.
主要方法:
- 一个小型聚胺类同类 (化合物2-7) 图书馆的合成.
- 评估MAO抑制功效和机制 (可逆性,竞争性).
- 使用LN-229人类质母细胞瘤细胞系对抗增殖活性的评估.
主要成果:
- 化合物4 (dianiline) 和5 (dianilide) 被确定为最强大的MAO抑制剂 (Ki <1μM).
- 这些化合物表现出可逆和主要具有竞争力的抑制.
- 化合物4和5在质母细胞瘤细胞中显示出显著的抗增殖作用 (GI50 < 1 μM).
结论:
- 聚胺支架可以被修改为产生强大的MAO抑制剂.
- 化合物4和5具有双重的MAO抑制和抗增殖特性.
- 化合物5的支架是开发针对MAO的新型抗癌药物的有希望的起点.
相关概念视频
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Adrenergic Agonists: Indirect-Acting Agents
1.7K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.7K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.1K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.1K
Antidepressant Drugs: MAOIs and Other Agents
270
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
270
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
715
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
715
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K


